insulin oral (NTRA-2112) / Nutrinia - LARVOL DELTA

Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants (clinicaltrials.gov) - P3 | N=300 | Terminated | Sponsor: Elgan Pharma Ltd. | N=530 ➔ 300 | Unknown status ➔ Terminated; Sponsor decision

Enrollment change • Trial termination